|
| << previous | next >> |
Journal description
All volumes of the corresponding journal
All issues of the corresponding volume
All articles of the corresponding issues
Details for article 4 of 13 found articles
| Title: |
If a drug deemed ‘safe’ in nonclinical tests subsequently prolongs QT in phase 1 studies, how can its sponsor convince regulators to allow development to proceed? |
| Author: |
Shah, Rashmi R. |
| Appeared in: |
Pharmacology & therapeutics |
| Paging: | Volume 119 (2008) nr. 2 pages 7 p. |
| Year: |
2008 |
| Contents: | |
| Publisher: |
Elsevier Inc. |
| Source file: |
Elektronische Wetenschappelijke Tijdschriften |
Details for article 4 of 13 found articles
| << previous | next >> |